Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07825350Phase 3Not yet recruiting
Phase 3, randomised trial in knee osteoarthritis (OA) comparing Standard of Care with SOC + Tranexamic Acid (2 arms). Primary endpoint: Haemoglobin value. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07825350.